Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Instituto de Investigaciones Clínicas Rosario
Instituto de Investigaciones Clínicas Rosario
Rosario, Santa Fe, Argentina, 2000
Select an option
I am a doctor
I am a sponsor
Contact
Our team
Medical staff
Maximilano Sicer
Open studies
Cardiovascular disease
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes -
CORALreef Outcomes - MK-0616-015 -
Merck Sharp & Dohme LLC
See more
Diabetes
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) -
Eli Lilly and Company
See more
Hypercholesterolemia
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes -
CORALreef Outcomes - MK-0616-015 -
Merck Sharp & Dohme LLC
See more
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent